First Description of mcr-1-Mediated Colistin Resistance in Human Infections Caused by Escherichia coli in Latin America

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4412-3. doi: 10.1128/AAC.00573-16. Print 2016 Jul.

Authors

Melina Rapoport¹, Diego Faccone¹, Fernando Pasteran¹, Paola Ceriana¹, Ezequiel Albornoz¹, Alejandro Petroni¹; MCR Group; Alejandra Corso²

Affiliations

¹ Servicio Antimicrobianos, National and Regional Reference Laboratory in Antimicrobial Resistance, Instituto Nacional de Enfermedades Infecciosas (INEI)-ANLIS Dr. C. Malbran, Buenos Aires, Argentina.
² Servicio Antimicrobianos, National and Regional Reference Laboratory in Antimicrobial Resistance, Instituto Nacional de Enfermedades Infecciosas (INEI)-ANLIS Dr. C. Malbran, Buenos Aires, Argentina acorso@anlis.gov.ar.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Anti-Bacterial Agents / pharmacology*
Argentina
Colistin / pharmacology*
Drug Resistance, Bacterial*
Escherichia coli / drug effects
Escherichia coli / enzymology*
Escherichia coli / genetics
Escherichia coli / isolation & purification
Escherichia coli Infections / drug therapy
Escherichia coli Infections / microbiology*
Escherichia coli Proteins / genetics*
Female
Humans
Male
Microbial Sensitivity Tests
Middle Aged

Substances

Anti-Bacterial Agents
Escherichia coli Proteins
MCR-1 protein, E coli
Colistin

Grants and funding

This work was supported by the regular federal budget of the National Ministry of Health of Argentina.